STOCK TITAN
  1. Home
  2. News
  3. CDLX

Cardlytics Inc - CDLX STOCK NEWS

Welcome to our dedicated news page for Cardlytics (Ticker: CDLX), a resource for investors and traders seeking the latest updates and insights on Cardlytics.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Cardlytics's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Cardlytics's position in the market.

News
Cardlytics Announces Timing of Its First Quarter 2024 Earnings Release
Rhea-AI Summary
Cardlytics, Inc. (NASDAQ: CDLX) has announced the timing for the release of its first quarter 2024 financial results, scheduled for May 8, 2024, after market close. Investors can join a live webcast or conference call to discuss the results.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
earnings
-
News
Liane Hornsey Appointed to Cardlytics Board of Directors
Rhea-AI Summary
Cardlytics, Inc. (NASDAQ: CDLX) appoints Liane Hornsey to its Board of Directors and Compensation Committee. Hornsey, a seasoned executive with experience at top tech companies, will bring valuable expertise to Cardlytics.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.98%
Tags
management
-
News
Cardlytics Prices $150.0 Million Convertible Senior Notes Offering
Rhea-AI Summary
Cardlytics, Inc. (NASDAQ: CDLX) announced the pricing of $150.0 million aggregate principal amount of 4.25% convertible senior notes due 2029 in a private offering. The notes will accrue interest at a rate of 4.25% per annum, payable semi-annually. Cardlytics estimates net proceeds of approximately $144.5 million, intending to use it to repurchase $183.9 million of its 1.00% convertible senior notes due 2025.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.65%
Tags
none
News
Cardlytics Announces Proposed Convertible Senior Notes Offering
Rhea-AI Summary
Cardlytics, Inc. (CDLX) announces a private offering of $150.0 million convertible senior notes due 2029 to qualified institutional buyers. The notes will be senior, unsecured obligations with interest payable semi-annually and maturity in 2029. Noteholders can convert notes under certain circumstances, with options for cash, shares, or a mix. Cardlytics plans to use proceeds for repurchasing 2025 Notes and general corporate purposes. The offering is not contingent on 2025 Notes repurchase.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-32.84%
Tags
none
-
News
Cardlytics Announces Fourth Quarter and Full Year 2023 Financial Results
Rhea-AI Summary
Cardlytics, Inc. (NASDAQ: CDLX) reported its financial results for Q4 and full year 2023, showing positive growth in revenue and key metrics. The company achieved a positive Adjusted EBITDA for the first time since 2019, with plans for double-digit billings growth in 2024 and positive operating cash flow. Despite a net loss attributable to common stockholders, Cardlytics improved its financial performance and aims to enhance its platform for partners and advertisers.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
77.15%
Tags
earnings
-
News
Cardlytics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Rhea-AI Summary
Cardlytics, Inc. (NASDAQ: CDLX) granted 198,183 restricted stock units to 8 new employees as inducements to employment under the 2022 Inducement Plan. The units have varying vesting schedules, with some vesting 100% on the first anniversary and others vesting 50% initially and the remaining 50% quarterly over the subsequent year.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.06%
Tags
none
News
Cardlytics Announces Timing of Its Fourth Quarter and Full Year 2023 Financial Results Conference Call and Webcast
Rhea-AI Summary
Cardlytics, Inc. (NASDAQ: CDLX) announced the release of its fourth-quarter financial results on March 14, 2024, followed by a conference call to discuss the company's performance.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.21%
Tags
earnings
-
News
Cardlytics Announces Successful Resolution of SRS Dispute and Preliminary Fourth Quarter 2023 Results
Rhea-AI Summary
Cardlytics, Inc. expects to achieve positive adjusted EBITDA for full year 2023, which would allow it to extend the maturity date of its credit facility until April 2025. The company entered into a settlement agreement with Shareholder Representative Services LLC, resolving all disputes related to the Bridg merger agreement and reported preliminary financial results for the fourth quarter ended December 31, 2023. The settlement agreement includes a cash payment of $25 million and issuance of 3.6 million shares of Cardlytics common stock to SRS. The company anticipates billings, revenue, adjusted contribution, and adjusted EBITDA to meet or exceed previous guidance for Q4 2023, indicating sustained profitability and flexibility in credit facility maturity.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
24.61%
Tags
earnings
-
News
Cardlytics Appoints Two New Members to its Board of Directors
Rhea-AI Summary
Cardlytics, Inc. (NASDAQ: CDLX) appoints Andre Fernandez and Jon Francis to its Board of Directors while John Balen and David Adams retire. Jack Klinck assumes the role of Chairperson of the Board. The new appointees bring expertise in financial strategy and data-driven analytics. Fernandez has leadership experience at WeWork, NCR, and General Electric, while Francis is the Chief Data and Analytics Officer at General Motors.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-12.36%
Tags
management
News
Cardlytics Announces Multi-Year Contract Renewal with Lloyds Bank Plc
Rhea-AI Summary
Cardlytics (NASDAQ: CDLX) Renews Spending Rewards Agreement with Lloyds Bank Plc
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.3%
Tags
none
Stock CDLX logo
Cardlytics Inc

Nasdaq:CDLX

CDLX Rankings

#2866 Ranked by Market Cap
#800 Ranked by Stock Gains
N/A Ranked by Dividends

CDLX Stock Data

598.56M
37.15M
3.68%
69.6%
13.49%
Other Services Related to Advertising
Professional, Scientific, and Technical Services
Link
United States
Atlanta

About CDLX

cardlytics uses purchase-based intelligence to make marketing more relevant and measurable. we partner with more than 2,000 financial institutions to run their banking rewards programs that promote customer loyalty and deepen banking relationships. in turn, we have a secure view into where and when consumers are spending their money. we use these insights to help marketers identify, reach and influence likely buyers at scale, as well as measure the true sales impact of marketing campaigns. at cardlytics, we are analysts, developers, and data scientists. we are marketers, account managers, and consultants to our clients. we are all focused on making sense of the data we see to make it informative and actionable for our partners. headquartered in atlanta, ga, with offices in new york city, london, san francisco, and chicago, our team rallies around a common desire to win and to help our clients win. we are focused on building a revolutionizing company, but we still care about each other